Nautilus Biotechnology Inc NAUT
$0.96
▼ -2.81%
($-0.03)
Open
$1.00
Prev Close
$0.99
Day Range
$0.96 – $1.04
52W Range
$0.70 – $4.31
Market Cap
$122.51M
Beta
0.86
EPS (TTM)
$-0.45
📋 Company Profile
| Industry | Life Sciences Tools & Services |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2020-08-07 |
| Shares Out. | 127,260,000 |
| Website | nautilus.bio ↗ |
| Phone | 12063332001 |
| Employees | 130 |
| Revenue | $190,000 |
| Gross Profit | $175,000 |
| Net Income | -$14.5M |
| Free Cash Flow | -$51.9M |
| Total Assets | $163.6M |
| Total Liabilities | $32.5M |
| Equity | $131.1M |
About Nautilus Biotechnology Inc
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.
Nautilus Biotechnology Inc is a publicly traded company under the ticker symbol NAUT on the NASDAQ NMS - GLOBAL MARKET, operating in the Life Sciences Tools & Services industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
8 analysts (2026-09-01)